Boca Biolistics
Private Company
Funding information not available
Overview
Boca Biolistics is a specialized contract research organization (CRO) and biobank that provides critical research materials and laboratory services to the life sciences industry. Its core business revolves around procuring and storing high-quality, clinically characterized biospecimens (biofluids, tissues, PBMCs) and offering central lab testing and clinical trial management services. With a global network spanning over 50 countries and 120+ collection sites, the company positions itself as a one-stop partner to accelerate research from early discovery through product launch, particularly in areas like infectious disease, oncology, and autoimmune disorders. Its value proposition is based on reliable sourcing, rapid turnaround, and regulatory-compliant data.
Technology Platform
Integrated service platform comprising a global biospecimen procurement network, a CAP/CLIA-certified central laboratory for clinical testing and assay validation, and a full suite of clinical trial management services.
Opportunities
Risk Factors
Competitive Landscape
Boca Biolistics competes with large, global CROs (e.g., LabCorp, IQVIA) that offer central lab services, as well as specialized biobanks and sample procurement firms. Its differentiation lies in its focused integration of procurement and validation testing for the IVD sector, its specific disease area expertise (e.g., infectious disease), and its emphasis on partnership and customer service.